Oral Testosterone

Product Details

User: Male

Hormonal: Yes

Delivery Method: Oral

Duration Type: Short-acting

Duration: One day

Regimen:
  • daily

Active Pharmaceutical Ingredient (API):
  • testosterone

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: University of Washington, GlaxoSmithKline, NICHD

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase I

Active Development: Unknown

Additional Information

References:

  • ClinicalTrials.gov Identifier: NCT01167829

Vertical Tabs

Print